GlobalData on MSN20d
FDA approves drug application for Lupin’s heart failure therapy
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and Valsartan tablets for heart failure patients. Sacubitril and Valsartan ...
Monthly Prescribing Reference5mon
Entresto Sprinkle
Sacubitril, valsartan; 6mg/6mg, 15mg/16mg; oral pellets in caps. Entresto Sprinkle is supplied as film-coated oral pellets are round, biconvex in shape, and provided in a hard capsule in the ...
Pharmabiz20d
Lupin receives US FDA approval for sacubitril and valsartan tablets
Global pharma major Lupin Limited (Lupin) announced that it has received United States Food and Drug Administration (FDA) approval for its Abbreviated new Drug Application (ANDA), sacubitril and ...
Medscape1mon
Valsartan vs. Amlodipine for Cardioprotection
in 31 countries to receive the angiotensin-receptor blocker valsartan or the calcium-channel blocker amlodipine. Doses were titrated over 6 months (daily maximums, 160 mg and 10 mg, respectively ...